课题基金 / 基金详情

项目摘要

项目成果

David Mu的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们已经通过冷泉港实验室 (CSHL) 开发的高分辨率基因组分析方法完成了对 250 多个肺癌样本的分析。我们发现了 12 个主要的循环扩增子,其中大多数包含已知的驱动基因,例如 MYC 或 KRAS2,另外三个则不包含,包括位于 14q13 的第二个最常见的扩增子。我们的第一个具体目标是对 14q13 频繁扩增区域内的所有三个候选驱动基因进行全面的功能评估。这项综合功能评估将利用 CSHL 开发的新 RNA 干扰技术进行功能获得转化测定和功能丧失测定,该技术可在体外和体内沉默基因表达。我们的初步数据表明,所有三个基因(每个基因编码不同的转录因子)协同促进肺上皮细胞的增殖。除了功能分析之外,我们还开展合作来解决 14q13 扩增的潜在诊断和预后意义。另外两个新的频繁扩增子包含几个候选基因。为了解决包含许多过表达基因的扩增子功能分析固有的困难,我们的第二个具体目标是开发新的条形码RNA文库干扰技术,该技术能够并行地对许多基因进行功能分析,成为对具有大量候选驱动基因的扩增子进行功能分析的强大工具。我们的研究结果将为肺癌发生的分子基础提供新的见解,并应确定诊断这种高度致命癌症的关键治疗靶点和新策略。这项研究的第一个目标集中于发现最致命的肺癌之一的新致病基因并对其进行功能表征。第二个目标是创建一种基于基因功能的工具,使研究人员能够快速识别重复扩增的基因组区域内的因果基因,该基因组区域包含太多基因,无法通过逐个基因的方法进行研究。该研究提案的前瞻性研究进展预计将对未来肺癌的诊断和治疗产生积极影响。本研究的第一个目标集中于发现和功能表征 最致命的癌症之一——肺癌的新致病基因。的 第二个目标是创建一种基于基因功能的工具,使研究人员能够快速 识别重复扩增的基因组区域内的因果基因,该区域包含 许多基因需要通过逐个基因的方法进行研究。前沿研究进展 这项研究计划预计会对诊断和治疗产生积极影响 将来会得肺癌。
英文摘要
DESCRIPTION (provided by applicant): We have completed analysis of over 250 lung cancer samples by a high- resolution genome profiling method developed here at Cold Spring Harbor Laboratory (CSHL). We found twelve major recurrent amplicons, most of which contain known driver genes such as MYC or KRAS2, and three others that do not, including the second most frequent amplicon which is located at 14q13. Our first specific aim is to perform comprehensive functional evaluation of all three candidate driver genes within this frequently amplified region at 14q13. This comprehensive functional evaluation will utilize both gain-of-function transformation assays and loss-of-function assays using new RNA interference technology, developed here at CSHL, that silences gene expression in vitro and in vivo. We have preliminary data that indicates that all three genes, each encoding a different transcription factors, synergistically promote the proliferation of lung epithelial cells. In addition to functional analysis, we have formed collaborations to address the potential diagnostic and prognostic significance of 14q13 amplification. The other two novel frequent amplicons contain several candidate genes. To address the difficulty inherent in functional analysis of amplicons containing many overexpressed genes, our second specific aim is to develop new barcoded RNA library interference technology, which enables functional analysis of many genes in parallel, into a robust tool for functional analysis of amplicons with large numbers of candidate driver genes. Our results will produce new insights into the molecular basis of lung carcinogenesis and should identify key therapeutic targets and new strategies for diagnostics for this highly lethal cancer. The first goal of this study focuses on the discovery and functional characterization of novel causal genes of one of the most deadly forms of lung cancer. The second goal is to create a gene function-based tool to enable researchers to rapidly identify the causal gene within a recurrent amplified genomic region that contains too many genes to be studied by a gene-by-gene approach. Forward research progress of this research proposal is expected to positively impact the diagnosis and treatment of lung cancer in the future. The first goal of this study focuses on the discovery and functional characterization of novel causal genes of one of the most deadly forms of cancers ¿ lung cancer. The second goal is to create a gene function-based tool to enable researchers to rapidly identify the causal gene within a recurrent amplified genomic region that contains too many genes to be studied by a gene-by-gene approach. Forward research progress of this research proposal is expected to positively impact the diagnosis and treatment of lung cancer in the future.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s11684-012-0188-4
发表时间: 2012-06
期刊: FRONTIERS OF MEDICINE
影响因子: 8.1
作者: [Qi, Ji, Mu, David]
通讯作者: Mu, David
Roles of Thyroid Transcription Factor 1 in Lung Cancer Biology.
甲状腺转录因子 1 在肺癌生物学中的作用。
DOI: 10.1016/bs.vh.2017.05.007
发表时间: 2018
期刊: Vitamins and hormones
影响因子: --
作者: [Phelps,CodyA, Lai,Shao-Chiang, Mu,David]
通讯作者: Mu,David
DOI: 10.1038/srep19857
发表时间: 2016-02-25
期刊: Scientific reports
影响因子: 4.6
作者: [Wood LW, Cox NI, Phelps CA, Lai SC, Poddar A, Talbot C Jr, Mu D]
通讯作者: Mu D
DOI: 10.1016/j.canlet.2013.05.038
发表时间: 2013-08-28
期刊: CANCER LETTERS
影响因子: 9.7
作者: [Runkle, E. Aaron, Mu, David]
通讯作者: Mu, David
Modifier of Cancer Sensitivity to Statins
  • 批准号:
    9101012
  • 项目类别:
  • 资助金额:
    $15.93万
  • 财政年份:
    2016
  • 负责人:
    David Mu
  • 依托单位:
Modifier of Cancer Sensitivity to Statins
  • 批准号:
    9251790
  • 项目类别:
  • 资助金额:
    $19.12万
  • 财政年份:
    2016
  • 负责人:
    David Mu
  • 依托单位:
Identification and characterization of driver gene(s) in recurrent lung cancer am
Identification and characterization of driver gene(s) in recurrent lung cancer am
海外基金